Statement of Changes in Beneficial Ownership (4)
11 January 2022 - 12:01AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Kusserow Paul B. K. |
2. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC
[
AMED
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
See Remarks |
|
(Last)
(First)
(Middle)
3854 AMERICAN WAY, SUITE A |
3. Date of Earliest Transaction
(MM/DD/YYYY)
1/6/2022 |
|
(Street)
BATON ROUGE, LA 70816
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock | 9/15/2021 | | G |
V
| 17640 | D | $0 | 83764 | I | By Trust |
| Common Stock | 1/6/2022 | | A | | 17330 (1) | A | $0 | 349571 | D | |
| Common Stock | | | | | | | | 621 (2) | I | Through 401(k) Plan |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Restricted Stock Unit (Performance-Based Vesting) | (3) | 1/6/2022 | | A | | 5777 | | (3) | (3) | Common Stock | 5777.0 | $0 | 5777 | D | |
| Explanation of Responses: |
| (1) | The Issuer awarded the Reporting Person 17,330 time-based Restricted Stock Units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest on January 6, 2023, subject to certain vesting provisions as set forth in the award agreement for the RSUs. |
| (2) | The information in this report is based on a plan statement dated as of September 30, 2021. |
| (3) | The RSUs awarded are subject to performance-based vesting based on achievement of an identified performance goal for 2022 and will vest after the end of the 2022 fiscal year, based on the certification by the Compensation Committee of the achievement of the identified performance goal for 2022, subject to certain vesting provisions as set forth in the award agreement for the RSUs. |
Remarks:
CEO and Chairman of the Board |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Kusserow Paul B. K.
3854 AMERICAN WAY, SUITE A
BATON ROUGE, LA 70816 | X |
| See Remarks |
|
Signatures
|
| /s/ Jennifer R. Guckert, pursuant to a power of attorney | | 1/10/2022 |
| **Signature of Reporting Person | Date |
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Apr 2023 to Apr 2024
